Publicação
AstraZeneca equity research – how R&D success and patent protection culminate in long-term growth
| Resumo: | This Equity Research Report presents a thorough valuation and strategic analysis of AstraZeneca PLC, assessing its competitive positioning within the capital-intensive pharmaceutical industry. Moreover, it examines the therapeutic areas where the company has focused on, identifies growth momentum opportunities by serving unmet medical needs across key markets and invests consistently in digital solutions to enhance R&D success. These factors are incorporated in the valuation model to determine the true intrinsic value of AstraZeneca. |
|---|---|
| Autores principais: | Drumond, Margarida Silva |
| Assunto: | AstraZeneca Pharmaceuticals Healthcare Valuation |
| Ano: | 2026 |
| País: | Portugal |
| Tipo de documento: | dissertação de mestrado |
| Tipo de acesso: | acesso aberto |
| Instituição associada: | Universidade Nova de Lisboa |
| Idioma: | inglês |
| Origem: | Repositório Institucional da UNL |
| Resumo: | This Equity Research Report presents a thorough valuation and strategic analysis of AstraZeneca PLC, assessing its competitive positioning within the capital-intensive pharmaceutical industry. Moreover, it examines the therapeutic areas where the company has focused on, identifies growth momentum opportunities by serving unmet medical needs across key markets and invests consistently in digital solutions to enhance R&D success. These factors are incorporated in the valuation model to determine the true intrinsic value of AstraZeneca. |
|---|